First implication of MIP in bilateral microphthalmia with persistent fetal vasculature
American Journal of Medical Genetics Part A · 2023
DOI: 10.1002/ajmg.a.63133 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2023. Verfasst von Mélissa Santorini und 7 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology Department, Rothschild Foundation Hospital, Paris, France. Hauptthemen laut MEDLINE: Cataract, Cataract Extraction, Microphthalmos, Persistent Hyperplastic Primary Vitreous. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Persistent fetal vasculature (PFV) is a rare malformative ocular disorder resulting from the failure of the hyaloid vasculature to regress. The severity of the visual impairment is depending on the underlying eye defects, ranging from discreet hyaloid remnants to severe ocular anomalies. Although PFV is generally unilateral, sporadic and idiopathic, a genetic cause has been described in some individuals, especially those presenting with a bilateral and/or syndromic form of PFV. The genes occasionally described in PFV are most often responsible for a wide spectrum of ocular phenotypes such as ATOH7 or NDP , a gene also known to be involved in Norrie disease, a X‐linked vitreoretinopathy with extra‐ocular features. We describe here a patient with an ocular phenotype consisting in non‐syndromic bilateral PFV with cataract and microphthalmia, in whom a recurrent heterozygous de novo MIP disease‐causing variant was detected after using a dedicated 119‐ocular genes panel approach. Defects in the MIP gene are classically associated with dominant non‐syndromic congenital cataract without other ocular malformative features. Thus, this case highlights the value of exploring individuals with PFV, even those with non‐syndromic forms. It also broadens the phenotypic spectrum of the MIP gene, adding new insights into the gene networks underlying PFV pathophysiology, that remains unclear.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ophthalmology Department, Rothschild Foundation Hospital, Paris, France.
- Ophthalmology Department, Robert Debré University Hospital, Reims, France.
- Department of Medical Genetics, Purpan University Hospital, Toulouse, France.
- National Reference Centre for the Rare Ophthalmological Disorders (CARGO), Toulouse University Hospital, Toulouse, France.
- Radiology Department, Rothschild Foundation Hospital, Paris, France.
- Inserm 1214 ToNIC, Purpan University Hospital, Toulouse, France.
ORCID-Profile: Bertrand Chesneau
Zitieren
APA
Santorini, M., Chesneau, B., Koskas-Boublil, P., Metge, F., Caputo, G., Chassaing, N., Martin, G., & Plaisancié, J. (2023). First implication of MIP in bilateral microphthalmia with persistent fetal vasculature. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63133
Vancouver
Santorini M, Chesneau B, Koskas-Boublil P, Metge F, Caputo G, Chassaing N, et al. First implication of MIP in bilateral microphthalmia with persistent fetal vasculature. American Journal of Medical Genetics Part A. 2023. doi:10.1002/ajmg.a.63133
BibTeX
@article{Santorini2023,
author = {Santorini, Mélissa and Chesneau, Bertrand and Koskas-Boublil, Patricia and Metge, Florence and Caputo, Georges and Chassaing, Nicolas and Martin, Gilles and Plaisancié, Julie},
title = {First implication of MIP in bilateral microphthalmia with persistent fetal vasculature},
journal = {American Journal of Medical Genetics Part A},
year = {2023},
doi = {10.1002/ajmg.a.63133}
}
EUVIMED